What this means
This is a trial that is still signing up people, so no results exist yet. It will test whether brief low-oxygen breathing helps blood vessels in the brain, compared with a placebo.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 60–85
- Where
- 1 site, including Iowa
The science
- Registered title
- IH, Brain Health, and T2D
- Trial ID
- NCT07173543 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Type 2 Diabetes, Aging
- What is tested
- Intermittent Hypoxia 1 (IH1), Intermittent Hypoxia 2 (IH2), SHAM - normoxia
- Sponsor
- Darren P Casey
- Ages
- 60 Years to 85 Years
- Dates
- First posted Sep 15, 2025 · updated Mar 13, 2026
Registry summary
The purpose of this study is to use a randomized, placebo-controlled study design to rigorously examine the therapeutic potential of intermittent hypoxia (IH) for improving cerebrovascular health in older adults with and without type 2 diabetes mellitus (T2DM).
Sites (1)
- University of Iowa, Iowa City, Iowa, United States